The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://rebeccarmxa034505.wikififfi.com/2009748/retatrutide_vs_tirzepatide_a_comparative_analysis